ArticleMedicine2020

Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report.

Jeremy Fricke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.